Robert Alpern

Insider profile

Currently holds positions in Abbott Laboratories, Abbvie Inc and Tricida Inc

Positions

Position Company Period
Independent Director Abbott Laboratories Oct. 10, 2008 -
Independent Director Abbvie Inc Jan. 2, 2013 -
Independent Director Tricida Inc Oct. 1, 2013 -

Robert Alpern's trades of Abbvie Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
47.97
Quantity 745
Value US$4,949,232
Transaction date
Proposed sale
Price
27.08
Quantity 24,833
Value US$2,938,155
Transaction date
Proposed sale
Price
272.28
Quantity 3,558
Value US$2,971,469
Transaction date
Sale
Price
0.21
Quantity 131,879 -100.0%
Value US$27,695
Transaction date
Sale
Price
0.23
Quantity 27,584 -17.3%
Value US$6,344
Transaction date
Planned sale
Price
39.59
Quantity 1,000 -0.7%
Value US$39,590
Transaction date
Planned sale
Price
39.92
Quantity 1,159 -0.8%
Value US$46,267
Transaction date
Planned sale
Price
39.75
Quantity 227 -0.2%
Value US$9,023
Transaction date
Planned sale
Price
39.89
Quantity 1,605 -1.1%
Value US$64,023
Transaction date
Planned sale
Price
36.29
Quantity 1,000 -0.7%
Value US$36,290
Transaction date
Planned sale
Price
37.24
Quantity 346 -0.2%
Value US$12,885
Transaction date
Planned sale
Price
36.52
Quantity 9,654 -6.0%
Value US$352,564
Transaction date
Planned sale
Price
32.63
Quantity 21 -0.0%
Value US$685
Transaction date
Planned sale
Price
32.15
Quantity 461 -0.3%
Value US$14,821
Transaction date
Planned sale
Price
30.76
Quantity 518 -0.3%
Value US$15,934
Transaction date
Planned sale
Price
31.60
Quantity 1,000 -0.6%
Value US$31,600
Transaction date
Planned sale
Price
37.05
Quantity 3,000 -1.8%
Value US$111,150
Transaction date
Planned sale
Price
33.63
Quantity 14,000 -7.8%
Value US$470,820
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-26 2026-05-26 PrS Proposed sale
745
47.97
US$4,949,232
745 47.97 US$4,949,232
2026-05-15 2026-05-15 PrS Proposed sale
24,833
27.08
US$2,938,155
24,833 27.08 US$2,938,155
2026-04-27 2026-04-27 PrS Proposed sale
3,558
272.28
US$2,971,469
3,558 272.28 US$2,971,469
2022-11-25 2022-11-23 S Sale
131,879 -100.0%
0.21
US$27,695
131,879 -100.0% 0.21 US$27,695
2022-11-22 2022-11-21 S Sale
27,584 -17.3%
0.23
US$6,344
27,584 -17.3% 0.23 US$6,344
2019-11-27 2019-11-26 PlS Planned sale
1,000 -0.7%
39.59
US$39,590
1,000 -0.7% 39.59 US$39,590
2019-11-14 2019-11-12 PlS Planned sale
1,159 -0.8%
39.92
US$46,267
1,159 -0.8% 39.92 US$46,267
2019-11-07 2019-11-06 PlS Planned sale
227 -0.2%
39.75
US$9,023
227 -0.2% 39.75 US$9,023
2019-11-07 2019-11-05 PlS Planned sale
1,605 -1.1%
39.89
US$64,023
1,605 -1.1% 39.89 US$64,023
2019-10-29 2019-10-25 PlS Planned sale
1,000 -0.7%
36.29
US$36,290
1,000 -0.7% 36.29 US$36,290
2019-10-29 2019-10-25 PlS Planned sale
346 -0.2%
37.24
US$12,885
346 -0.2% 37.24 US$12,885
2019-10-29 2019-10-25 PlS Planned sale
9,654 -6.0%
36.52
US$352,564
9,654 -6.0% 36.52 US$352,564
2019-09-30 2019-09-26 PlS Planned sale
21 -0.0%
32.63
US$685
21 -0.0% 32.63 US$685
2019-09-30 2019-09-26 PlS Planned sale
461 -0.3%
32.15
US$14,821
461 -0.3% 32.15 US$14,821
2019-09-30 2019-09-26 PlS Planned sale
518 -0.3%
30.76
US$15,934
518 -0.3% 30.76 US$15,934
2019-07-29 2019-07-25 PlS Planned sale
1,000 -0.6%
31.60
US$31,600
1,000 -0.6% 31.60 US$31,600
2019-07-05 2019-07-03 PlS Planned sale
3,000 -1.8%
37.05
US$111,150
3,000 -1.8% 37.05 US$111,150
2019-03-29 2019-03-28 PlS Planned sale
14,000 -7.8%
33.63
US$470,820
14,000 -7.8% 33.63 US$470,820